about
Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meningesTime-dependent effects of theophylline on myocardial reactive hyperaemias in the anaesthetized dog.Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung diseaseMultiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.Moxalactam pharmacokinetics in childrenSimplified approaches to the determination of antipyrine pharmacokinetic parameters.Benzodiazepines: a summary of pharmacokinetic propertiesPharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteersInfluence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acidPharmacokinetics of ofloxacin after parenteral and oral administrationPharmacokinetics of ciprofloxacin after oral and parenteral administration.Pharmacokinetics of moxalactam in patients with renal insufficiencyPharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteersEffects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.Netilmicin and gentamicin: comparative pharmacology in humans.Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distributionA Case-Based Approach to Integrating Opioid Pharmacokinetic and Pharmacodynamic Concepts in Cancer Pain Management.Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model.Clinical pharmacokinetics of lorazepam. IV. Long-term oral administration.Deranged tyrosine metabolism in cirrhosis.'MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics.Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.Pharmacokinetics of a novel quinolone, AT-4140, in animals.Disposition and metabolism of benoxaprofen in laboratory animals and man.The elderly patient in the coronary care unit. II. Incidence and treatment of arrhythmias.The bioavailability of intranasal lignocaine.Serum methotrexate in childhood ALL.Comparative pharmacokinetics of ceftazidime and moxalactam.Population study of triazolam pharmacokinetics.The utility of pharmacokinetics to the pharmaceutical industry.Copper-64 labeled liposomes for imaging bone marrow.The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
P2860
Q24561957-81217582-9586-461A-8D19-0A11D63F4180Q30443953-420506E4-3AAD-4C4E-A6E6-94F61B8F16D2Q30449218-EF5FB567-33D4-4A94-B69C-945F1AC93F88Q33580826-255445A4-CF3C-4675-9D5F-2FF21FA037D0Q33750540-C5BB5DAA-C223-47C5-9855-E519B023AB32Q34250667-39142928-BAC5-4C6F-8CD7-DE9D86FBEA3FQ34417536-B779EDEC-EAEE-4514-A279-0E5ABFA5A87EQ34448708-768111AA-E5AA-4299-B429-B10DBD837309Q35285981-90512A62-3FF6-4713-AD04-84DEA41DF1AFQ35289147-3AC57BE8-B3FA-46A1-AEC5-859406B71229Q35359282-FE341EE0-BF06-4856-A102-455BB6D0E4D8Q35541436-3EE7E78D-FF8F-4D58-8BB4-CBDE9ED8DD58Q35570646-38971C70-057F-4920-AA5A-A99F0844E853Q35669119-1498AF9A-64E2-439A-ACFF-8C37C50D9E1EQ35716241-C45396F4-3A07-4AB7-8D16-CDDCDEC0BCB3Q35740078-5636A68A-21B9-46F7-A057-F8E6801A7588Q35753896-E2EB8DB4-1336-4DCA-B90A-6F3FDE684C26Q35819061-77B78BEF-B6B9-430A-878F-E0624571F598Q35843432-CB94369A-EFA9-4D04-9230-F2E2DD88CCA7Q35897391-7181BC61-389B-4341-BCBD-94E22582FD8BQ36461552-E7F66559-0274-4E34-800F-80593F4B72C5Q36473500-D5ED732E-8625-4922-96D7-0A8FB9F152C8Q36480486-24F9315C-E793-4F08-A3F8-2BBADFB422D2Q38655206-48ACC43E-081A-4AC5-9887-A9D7D40F52E7Q38963898-86836664-16D9-4939-8845-7C8C32AAF3DEQ39160487-135A940E-CBC7-460A-8EE5-D5FC5B613AB5Q39254570-CED615C0-58EF-4B26-9A32-A8B38FA60782Q39367991-7DFDF98E-D87D-4B0B-A82E-5C81E39A8251Q39781204-DF7B5D34-5FFE-42F3-A7E7-26FFBF9009AEQ39815188-B6D8DA2F-5792-4FCC-8AAA-1F425555CE63Q41416983-5455C114-AA19-4CD1-8738-86E7011C06FBQ41502170-7D5F18FE-0175-4547-9E7C-E11D72F3A340Q42026424-5CEC3237-E168-4816-9399-046EA624E8A2Q42371615-72ADE06F-3F13-47E5-A4BB-7571AEC290B9Q42926813-C3A05AB2-A8E9-4557-85A7-B14A972EBCFDQ43240659-BF9A6E57-9E44-496C-A610-806C5DBBF18DQ44546055-FF60EF17-A73C-4CDC-BC83-DFE9A85BD919Q47262018-2CD34C5B-C1F6-4335-892E-2AA34B4A4874Q50591167-443C8C51-79E9-497F-8E83-D007D0DED5FFQ51112914-E8119365-A682-4281-864E-CC79477EA5B5
P2860
description
1975 nî lūn-bûn
@nan
1975 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Clinical pharmacokinetics (second of two parts).
@ast
Clinical pharmacokinetics (second of two parts).
@en
Clinical pharmacokinetics
@nl
type
label
Clinical pharmacokinetics (second of two parts).
@ast
Clinical pharmacokinetics (second of two parts).
@en
Clinical pharmacokinetics
@nl
prefLabel
Clinical pharmacokinetics (second of two parts).
@ast
Clinical pharmacokinetics (second of two parts).
@en
Clinical pharmacokinetics
@nl
P1476
Clinical pharmacokinetics (second of two parts).
@en
P2093
Greenblatt DJ
Koch-Weser J
P304
P356
10.1056/NEJM197511062931905
P407
P577
1975-11-01T00:00:00Z